chevron_leftBack
Shandong Jincheng Pharmaceutical Group Co., Ltd.
300233
16.74CNY
3.7%
2.30 USD
As of 24 April 2025, Shandong Jincheng Pharmaceutical Group Co., Ltd. has a market cap of $840.7M USD, ranking #9031 globally and #2567 in China. It ranks #886 in the Basic Materials sector, and #137 in the Chemicals industry.
Key Stats
Market Cap
$840.7MUSD
6.13B CNY
Enterprise Value
$794.47MUSD
5.79B CNY
Revenue (TTM)
$462.93MUSD
3.37B CNY
EBITDA (TTM)
$79.88MUSD
582.11M CNY
Net Income (TTM)
$27.0MUSD
196.78M CNY
EBITDA Margin
17%
Profit Margin
5.8%
PE Ratio
31.1
Company Profile
Country (HQ)
Sector
Basic Materials
Industry
Chemicals
CEO
Jiaquan Li
open_in_new
Employees
3,657
Founded
2004
Website
jinchengpharm.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 3.7% | -2.1% | -13% | 24% | 17% | 5.9% |
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
300233
山东金城医药集团股份有限公司 Class A
ISIN: CNE100001500
Shares Out.:
Shares Outstanding:
379.332M1
Shares Float:
296.858M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
16.74 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Shandong Jincheng Pharmaceutical Group Co., Ltd.
Shandong Jincheng Pharmaceutical Group Co., Ltd researches and develops, produces, markets, and sells Cephalosporin intermediates in China and internationally. The company offers medical intermediate, animal nutrition, health care, CMO, CDMO, pharmaceuticals, API, finished dosage, and fine chemicals. Shandong Jincheng Pharmaceutical Group Co., Ltd was founded in 2004 and is based in Zibo, China.
